All data are based on the daily closing price as of July 18, 2025
t
Towa Pharmaceutical
4553.TSE
21.57 USD
0.04
+0.19%
Overview
Last close
21.57 usd
Market cap
1.06B usd
52 week high
22.81 usd
52 week low
16.24 usd
Target price
27.41 usd
Valuation
P/E
8.3126
Forward P/E
16.7785
Price/Sales
0.6078
Price/Book Value
0.9193
Enterprise Value
2.31B usd
EV/Revenue
1.3224
EV/EBITDA
7.1434
Key financials
Revenue TTM
1.74B usd
Gross Profit TTM
636.49M usd
EBITDA TTM
291.22M usd
Earnings per Share
2.59 usd
Dividend
0.47 usd
Total assets
3.16B usd
Net debt
1.24B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.